Operating responsibly
GSK is collaborating with companies and research groups across the world working on promising COVID-19 vaccine candidates through the use of our innovative vaccine adjuvant technology.
“The fact remains we may never get a vaccine and if we do get one, we have to be prepared that it may not be a vaccine which prevents getting the virus, but rather one that reduces symptoms.” Active discussions on supply of the vaccine are ongoing with global organizations, the US and the EU Commission - with France and Italy on the negotiation team.
Corporate reporting Registered in England and Wales No. We are a global company delivering billions of healthcare products a year. Trials in people
PARIS and LONDON - July 29, 2020 - Sanofi and GSK have reached an agreement, subject to final contract, with the UK government for the supply of up to 60 million doses of a …
Financial calendar Culture and values
8 September 2003 Linda a. Johnson for Associated Press 8 February 2012 Genetic Engineering and Biotechnology News. Unfortunately, even though Sanofi-GSK approach is based on pre-existing, approved platform and technology (as with Flublok flu) without reinventing the wheel of the necessary infrastructureEric Palmer and Carly Helfand for FiercePharma.
Explore innovations in medicines, vaccines and consumer healthcare from inside and outside our labs
Adverse events To report a suspected adverse event (side effect) from one of our products: Opening office hours: 09.00 - 17.00 (Monday to Thursday) 09.00 - 16.00 (Friday) The partners plan to provide a significant portion of total worldwide available supply capacity in 2021/22, to the global initiative“Access to COVID‐19 Tools (ACT) Accelerator”, a global collaboration of leaders of governments, global health organizations, businesses and philanthropies to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.
Going the Distance: Delivering influenza vaccines no matter what. All Press Releases.
Our Stories.
Please don’t hesitate to contact us for question or remarks.This website is intended for Healthcare Professionals based in the United Kingdom only. Meet some of our employees from various roles, and find out what they really think about working life with us.
Speeches & presentations Watch the video. In early 2004, Sanofi-Synthélabo made a In 2006, Iraqis infected with HIV sued Sanofi and Baxter due to HIV-In 2007, Sanofi-Aventis expanded on Aventis' prior relationship with Between 2008, when Chris Viebacher was hired as CEO, and 2010, the company spent more than $17 billion in mergers and acquisitions to strengthen its consumer healthcare and generics platforms, especially in emerging markets, in the face of looming In 2009, Medley Farma, the third largest pharmaceutical company in Brazil and a leading generics company in that country, was acquired for about $635 million.The company dropped the -Aventis suffix of its name on 6 May 2011, after receiving approval at its In January 2012, Sanofi co-invested in the $125 million In March 2014, Sanofi joined the bidding for Merck & Co.'s over-the-counter health-products unit, the maker of In October 2014, Sanofi's directors fired US-resident chief executive Chris Viehbacher, blaming his alleged lack of communication with the board and poor execution of his strategy.In June 2016, the company announced it had struck an asset-swap deal with In July 2017, the company announced its intention to acquire Protein Sciences, a privately held, Connecticut-based vaccines biotechnology company, for $650 million and with up to $100 million in milestone achievements.In January 2018, Sanofi announced that it would acquire In December 2019, the company announced it would acquire Synthorx for $2.5 billion ($68 per share), adding the lead product candidate THOR-707, a form of The following products are found on the Sanofi website.
Discover. Shareholder information
If the data are positive, regulatory approval could be achieved by the first half of 2021. Policies, codes and standards
Keep up to date with our news and recent announcements
Apprentices, students and graduates